Peripheral and central inflammation in autism spectrum disorders

Molecular and Cellular Neuroscience

Volumn 53, Issue , 2013, Pages 69-76

  Depino, Amaicha Mara ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Animal model; Autism spectrum disorders; Behavior; Cytokines; Immune activation; Inflammation

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULTHOOD; ARTICLE; ASTROCYTOSIS; AUTISM; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BEHAVIOR; BRAIN DEVELOPMENT; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIGENETIC REPRESSION; FETUS DEVELOPMENT; GESTATIONAL AGE; GLIA CELL; HEREDITY; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; MOLECULAR MECHANICS; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPSYCHIATRY; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PERIPHERAL NERVOUS SYSTEM; POSTNATAL DEVELOPMENT; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ANIMALS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CYTOKINES; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFLAMMATION;

ANIMALIA; RODENTIA;

EID: 84873322584     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.10.003     Document Type: Article

References (127)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
2. Abdallah M.W., Larsen N., Grove J., Norgaard-Pedersen B., Thorsen P., Mortensen E.L., Hougaard D.M. Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav. Immun. 2012, 26:170-176.
3. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9:341-355.
4. Adams-Chapman I., Stoll B.J. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr. Opin. Infect. Dis. 2006, 19:290-297.
5. Aly H., Khashaba M.T., El-Ayouty M., El-Sayed O., Hasanein B.M. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006, 28:178-182.
6. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends Neurosci. 2008, 31:137-145.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Text Revision, American Psychiatric Publishing, Inc., Washington, DC. Fourth ed.
8. Anderson G.M., Jacobs-Stannard A., Chawarska K., Volkmar F.R., Kliman H.J. Placental trophoblast inclusions in autism spectrum disorder. Biol. Psychiatry 2007, 61:487-491.
9. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol. Psychiatry 2006, 11:47-55.
10. Atladottir H.O., Pedersen M.G., Thorsen P., Mortensen P.B., Deleuran B., Eaton W.W., Parner E.T. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124:687-694.
11. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., Parner E.T. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40:1423-1430.
12. Atladottir H.O., Henriksen T.B., Schendel D.E., Parner E.T. Using maternally reported data to investigate the association between early childhood infection and autism spectrum disorder: the importance of data source. Paediatr. Perinat. Epidemiol. 2012, 26:373-385.
13. Barak Y., Kimhi R., Stein D., Gutman J., Weizman A. Autistic subjects with comorbid epilepsy: a possible association with viral infections. Child Psychiatry Hum. Dev. 1999, 29:245-251.
14. Baron-Cohen S., Scott F.J., Allison C., Williams J., Bolton P., Matthews F.E., Brayne C. Prevalence of autism-spectrum conditions: UK school-based population study. Br. J. Psychiatry 2009, 194:500-509.
15. Becker K.G. Autism, asthma, inflammation, and the hygiene hypothesis. Med. Hypotheses 2007, 69:731-740.
16. Berg R. Autism-an environmental health issue after all?. J. Environ. Health 2009, 71:14-18.
17. Besedovsky H.O., Rey A.D. Physiology of psychoneuroimmunology: a personal view. Brain Behav. Immun. 2007, 21:34-44.
18. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 2005, 25:8000-8009.
19. Bilousova T.V., Dansie L., Ngo M., Aye J., Charles J.R., Ethell D.W., Ethell I.M. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J. Med. Genet. 2009, 46:94-102.
20. Bluthe R.M., Walter V., Parnet P., Laye S., Lestage J., Verrier D., Poole S., Stenning B.E., Kelley K.W., Dantzer R. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C. R. Acad. Sci. III 1994, 317:499-503.
21. Bluthe R.M., Michaud B., Poli V., Dantzer R. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 2000, 70:367-373.
22. Bluthe R.M., Lestage J., Rees G., Bristow A., Dantzer R. Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats. Neuropsychopharmacology 2002, 26:86-93.
23. Boisse L., Mouihate A., Ellis S., Pittman Q.J. Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide. J. Neurosci. 2004, 24:4928-4934.
24. Braunschweig D., Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 2008, 29:226-231.
25. Cai Z., Pan Z.L., Pang Y., Evans O.B., Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 2000, 47:64-72.
26. Centers for Disease Control and Prevention Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006 2009, Surveillance Summaries, MMWR.
27. Chess S. Autism in children with congenital rubella. J. Autism Child. Schizophr. 1971, 1:33-47.
28. Chess S. Follow-up report on autism in congenital rubella. J. Autism Child. Schizophr. 1977, 7:69-81.
29. Chez M.G., Guido-Estrada N. Immune therapy in autism: historical experience and future directions with immunomodulatory therapy. Neurotherapeutics 2010, 7:293-301.
30. Chez M.G., Dowling T., Patel P.B., Khanna P., Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr. Neurol. 2007, 36:361-365.
31. Ciaranello A.L., Ciaranello R.D. The neurobiology of infantile autism. Annu. Rev. Neurosci. 1995, 18:101-128.
32. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999, 14:388-394.
33. Crawley J.N. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 2007, 17:448-459.
34. Croen L.A., Braunschweig D., Haapanen L., Yoshida C.K., Fireman B., Grether J.K., Kharrazi M., Hansen R.L., Ashwood P., Van de Water J. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 2008, 64:583-588.
35. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 2002, 45:1-6.
36. Curran L.K., Newschaffer C.J., Lee L.C., Crawford S.O., Johnston M.V., Zimmerman A.W. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 2007, 120:e1386-e1392.
37. Dalton P., Deacon R., Blamire A., Pike M., McKinlay I., Stein J., Styles P., Vincent A. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 2003, 53:533-537.
38. DeLong G.R., Bean S.C., Brown F.R. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch. Neurol. 1981, 38:191-194.
39. Depino A.M. Maternal infection and the offspring brain. J. Neurosci. 2006, 26:7777-7778.
40. Depino A.M., Lucchina L., Pitossi F. Early and adult hippocampal TGF-beta1 overexpression have opposite effects on behavior. Brain Behav. Immun. 2011, 25:1582-1591.
41. D'Souza Y., Dionne S., Seidman E.G., Bitton A., Ward B.J. No evidence of persisting measles virus in the intestinal tissues of patients with inflammatory bowel disease. Gut 2007, 56:886-888.
42. Emanuele E., Orsi P., Boso M., Broglia D., Brondino N., Barale F., di Nemi S.U., Politi P. Low-grade endotoxemia in patients with severe autism. Neurosci. Lett. 2010, 471:162-165.
43. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav. Immun. 2010, 24:64-71.
44. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., Shier A., Sheikh S., Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry 1999, 4:145-154.
45. Fatemi S.H., Emamian E.S., Sidwell R.W., Kist D.A., Stary J.M., Earle J.A., Thuras P. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol. Psychiatry 2002, 7:633-640.
46. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., Smee D.F., Pearce D.A., Winter C., Sohr R., Juckel G. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr. Res. 2008, 99:56-70.
47. Flaherty D.K. The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science. Ann. Pharmacother. 2011, 45:1302-1304.
48. Garbett K., Ebert P.J., Mitchell A., Lintas C., Manzi B., Mirnics K., Persico A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 2008, 30:303-311.
49. Ghaziuddin M., Tsai L.Y., Eilers L., Ghaziuddin N. Brief report: autism and herpes simplex encephalitis. J. Autism Dev. Disord. 1992, 22:107-113.
50. Gillberg C. Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J. Autism Dev. Disord. 1986, 16:369-375.
51. Golan H.M., Lev V., Hallak M., Sorokin Y., Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 2005, 48:903-917.
52. Graciarena M., Depino A.M., Pitossi F.J. Prenatal inflammation impairs adult neurogenesis and memory related behavior through persistent hippocampal TGFbeta(1) downregulation. Brain Behav. Immun. 2010, 24:1301-1309.
53. Granger D.A., Hood K.E., Ikeda S.C., Reed C.L., Block M.L. Neonatal endotoxin exposure alters the development of social behavior and the hypothalamic-pituitary-adrenal axis in selectively bred mice. Brain Behav. Immun. 1996, 10:249-259.
54. Greer M.K., Lyons-Crews M., Mauldin L.B., Brown F.R. A case study of the cognitive and behavioral deficits of temporal lobe damage in herpes simplex encephalitis. J. Autism Dev. Disord. 1989, 19:317-326.
55. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., Lotspeich L., Croen L.A., Ozonoff S., Lajonchere C., Grether J.K., Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 2011, 68:1095-1102.
56. Heo Y., Zhang Y., Gao D., Miller V.M., Lawrence D.A. Aberrant immune responses in a mouse with behavioral disorders. PLoS One 2011, 6:e20912.
57. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20:84-90.
58. Hood K.E., Dreschel N.A., Granger D.A. Maternal behavior changes after immune challenge of neonates with developmental effects on adult social behavior. Dev. Psychobiol. 2003, 42:17-34.
59. Hornig M., Briese T., Buie T., Bauman M.L., Lauwers G., Siemetzki U., Hummel K., Rota P.A., Bellini W.J., O'Leary J.J., Sheils O., Alden E., Pickering L., Lipkin W.I. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLoS One 2008, 3:e3140.
60. Hsiao E.Y., McBride S.W., Chow J., Mazmanian S.K., Patterson P.H. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:12776-12781.
61. Hu V.W., Sarachana T., Kim K.S., Nguyen A., Kulkarni S., Steinberg M.E., Luu T., Lai Y., Lee N.H. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009, 2:78-97.
62. Ivarsson S.A., Bjerre I., Vegfors P., Ahlfors K. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990, 21:102-103.
63. Jyonouchi H., Sun S., Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 2001, 120:170-179.
64. Jyonouchi H., Sun S., Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002, 46:76-84.
65. Khazipov R., Luhmann H.J. Early patterns of electrical activity in the developing cerebral cortex of humans and rodents. Trends Neurosci. 2006, 29:414-418.
66. Khazipov R., Sirota A., Leinekugel X., Holmes G.L., Ben-Ari Y., Buzsaki G. Early motor activity drives spindle bursts in the developing somatosensory cortex. Nature 2004, 432:758-761.
67. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002, 25:154-159.
68. Konsman J.P., Veeneman J., Combe C., Poole S., Luheshi G.N., Dantzer R. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur. J. Neurosci. 2008, 28:2499-2510.
69. Landrigan P.J. What causes autism? Exploring the environmental contribution. Curr. Opin. Pediatr. 2010, 22:219-225.
70. Larsson M., Weiss B., Janson S., Sundell J., Bornehag C.G. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8 years of age. Neurotoxicology 2009, 30:822-831.
71. Leinekugel X., Khazipov R., Cannon R., Hirase H., Ben-Ari Y., Buzsaki G. Correlated bursts of activity in the neonatal hippocampus in vivo. Science 2002, 296:2049-2052.
72. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 2009, 207:111-116.
73. Libbey J.E., Fujinami R.S. Role for antibodies in altering behavior and movement. Autism Res. 2010, 3:147-152.
74. Lintas C., Altieri L., Lombardi F., Sacco R., Persico A.M. Association of autism with polyomavirus infection in postmortem brains. J. Neurovirol. 2010, 16:141-149.
75. Liu J., Feng Z.C. Increased umbilical cord plasma interleukin-1 beta levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J. Trop. Pediatr. 2010, 56:178-182.
76. Lucchina L., Carola V., Pitossi F., Depino A.M. Evaluating the interaction between early postnatal inflammation and maternal care in the programming of adult anxiety and depression-related behaviors. Behav. Brain Res. 2010, 213:56-65.
77. MacFabe D.F., Cain D.P., Rodriguez-Capote K., Franklin A.E., Hoffman J.E., Boon F., Taylor A.R., Kavaliers M., Ossenkopp K.P. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 2007, 176:149-169.
78. MacFabe D.F., Cain N.E., Boon F., Ossenkopp K.P., Cain D.P. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav. Brain Res. 2011, 217:47-54.
79. Malek A., Sager R., Lang A.B., Schneider H. Protein transport across the in vitro perfused human placenta. Am. J. Reprod. Immunol. 1997, 38:263-271.
80. Malik M., Sheikh A.M., Wen G., Spivack W., Brown W.T., Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011, 216:80-85.
81. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 2012, 26:607-616.
82. Mandal M., Marzouk A.C., Donnelly R., Ponzio N.M. Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells. Brain Behav. Immun. 2011, 25:863-871.
83. Markowitz P.I. Autism in a child with congenital cytomegalovirus infection. J. Autism Dev. Disord. 1983, 13:249-253.
84. Martin L.Acb., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 2008, 22:806-816.
85. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev. Neurosci. 1992, 14:1-10.
86. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 2006, 26:4752-4762.
87. Miller L.C., Isa S., LoPreste G., Schaller J.G., Dinarello C.A. Neonatal interleukin-1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J. Pediatr. 1990, 117:961-965.
88. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., Dean J.C. A clinical study of 57 children with fetal anticonvulsant syndromes. J. Med. Genet. 2000, 37:489-497.
89. Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J., Courchesne E., Everall I.P. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 2010, 68:368-376.
90. Moy S.S., Nadler J.J. Advances in behavioral genetics: mouse models of autism. Mol. Psychiatry 2008, 13:4-26.
91. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., Barbaro J.R., Wilson L.M., Threadgill D.W., Lauder J.M., Magnuson T.R., Crawley J.N. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 2007, 176:4-20.
92. Myint A.M., Schwarz M.J., Steinbusch H.W., Leonard B.E. Neuropsychiatric disorders related to interferon and interleukins treatment. Metab. Brain Dis. 2009, 24:55-68.
93. Palmen S.J., van Engeland H., Hof P.R., Schmitz C. Neuropathological findings in autism. Brain 2004, 127:2572-2583.
94. Paribello C., Tao L., Folino A., Berry-Kravis E., Tranfaglia M., Ethell I.M., Ethell D.W. Open-label add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol. 2010, 10:91.
95. Parracho H.M., Bingham M.O., Gibson G.R., McCartney A.L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 2005, 54:987-991.
96. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol. 2002, 12:115-118.
97. Ring A., Barak Y., Ticher A., Ashkenazi I., Elizur A., Weizman A. Evidence for an infectious etiology in autism. Pathophysiology 1997, 4:91-96.
98. Roberts E.M., English P.B., Grether J.K., Windham G.C., Somberg L., Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ. Health Perspect. 2007, 115:1482-1489.
99. Rodier P.M. Chronology of neuron development: animal studies and their clinical implications. Dev. Med. Child Neurol. 1980, 22:525-545.
100. Rosen N.J., Yoshida C.K., Croen L.A. Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 2007, 119:e61-e69.
101. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1345-R1356.
102. Saresella M., Marventano I., Guerini F.R., Mancuso R., Ceresa L., Zanzottera M., Rusconi B., Maggioni E., Tinelli C., Clerici M. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol. Psychiatry 2009, 66:978-984.
103. Saunders N.R., Knott G.W., Dziegielewska K.M. Barriers in the immature brain. Cell. Mol. Neurobiol. 2000, 20:29-40.
104. Shanks N., Windle R.J., Perks P.A., Harbuz M.S., Jessop D.S., Ingram C.D., Lightman S.L. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5645-5650.
105. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
106. Shi L., Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 2009, 23:116-123.
107. Shultz S.R., MacFabe D.F., Ossenkopp K.P., Scratch S., Whelan J., Taylor R., Cain D.P. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 2008, 54:901-911.
108. Shultz S.R., Macfabe D.F., Martin S., Jackson J., Taylor R., Boon F., Ossenkopp K.P., Cain D.P. Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav. Brain Res. 2009, 200:33-41.
109. Singh V.K., Jensen R.L. Elevated levels of measles antibodies in children with autism. Pediatr. Neurol. 2003, 28:292-294.
110. Singh V.K., Lin S.X., Yang V.C. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin. Immunol. Immunopathol. 1998, 89:105-108.
111. Singh V.K., Lin S.X., Newell E., Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J. Biomed. Sci. 2002, 9:359-364.
112. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
113. Stolp H.B., Dziegielewska K.M. Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 2009, 35:132-146.
114. Stromland K., Nordin V., Miller M., Akerstrom B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 1994, 36:351-356.
115. Stubbs E.G. Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J. Autism Child. Schizophr. 1976, 6:269-274.
116. Stubbs E.G. Autistic symptoms in a child with congenital cytomegalovirus infection. J. Autism Child. Schizophr. 1978, 8:37-43.
117. Suzuki K., Matsuzaki H., Iwata K., Kameno Y., Shimmura C., Kawai S., Yoshihara Y., Wakuda T., Takebayashi K., Takagai S., Matsumoto K., Tsuchiya K.J., Iwata Y., Nakamura K., Tsujii M., Sugiyama T., Mori N. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6:e20470.
118. Uhlmann V., Martin C.M., Sheils O., Pilkington L., Silva I., Killalea A., Murch S.B., Walker-Smith J., Thomson M., Wakefield A.J., O'Leary J.J. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol. Pathol. 2002, 55:84-90.
119. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
120. Wakefield A.J., Murch S.H., Anthony A., Linnell J., Casson D.M., Malik M., Berelowitz M., Dhillon A.P., Thomson M.A., Harvey P., Valentine A., Davies S.E., Walker-Smith J.A. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998, 351:637-641.
121. Wang L.W., Tancredi D.J., Thomas D.W. The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J. Dev. Behav. Pediatr. 2011, 32:351-360.
122. Williams C.L., Teeling J.L., Perry V.H., Fleming T.P. Mouse maternal systemic inflammation at the zygote stage causes blunted cytokine responsiveness in lipopolysaccharide-challenged adult offspring. BMC Biol. 2011, 9:49.
123. World Health Organization International Classification of Diseases 1994, 10th Revision, World Health Organization, Geneva, Switzerland.
124. Yamashita Y., Fujimoto C., Nakajima E., Isagai T., Matsuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. J. Autism Dev. Disord. 2003, 33:455-459.
125. Yoon B.H., Romero R., Kim C.J., Jun J.K., Gomez R., Choi J.H., Syn H.C. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am. J. Obstet. Gynecol. 1995, 172:960-970.
126. Ziats M.N., Rennert O.M. Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PLoS One 2011, 6:e24691.
127. Zimmerman A.W., Jyonouchi H., Comi A.M., Connors S.L., Milstien S., Varsou A., Heyes M.P. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr. Neurol. 2005, 33:195-201.